Novel vaccine scores better hepatitis B seroprotection in type 2 diabetes

NEW ORLEANS – An investigational hepatitis B vaccine known as Heplisav-B provided significantly better seroprotection among adults with type 2 diabetes than did a currently licensed vaccine, based on...
Source: Family Practice News - Category: Primary Care Source Type: news